Model-Informed Precision Dosing Using Machine Learning for Levothyroxine in General Practice: Development, Validation
Jules M Janssen Daalen1, Djoeke Doesburg2, Liesbeth Hunik3
1Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
Model-informed precision dosing (MIPD) using machine learning improves levothyroxine dosing in primary care. This AI tool reduced dosage errors and increased optimal starting doses, enhancing patient safety and treatment effectiveness.
Area of Science:
- Pharmacology
- Artificial Intelligence
- Clinical Medicine
Background:
- Levothyroxine is a widely prescribed medication with challenging dosing due to individual variability and a narrow therapeutic window.
- Current dosing practices in primary care lack advanced decision support, leading to potential under or overdosage.
- A gap exists between AI developers and clinicians, hindering the adoption of healthcare algorithms.
Purpose of the Study:
- To develop, validate, and clinically simulate the first model-informed precision dosing (MIPD) application for levothyroxine in primary care.
- To assess the safety, feasibility, and clinical impact of MIPD compared to traditional dosing methods.
- To improve the accuracy of initial levothyroxine dosage selection by general practitioners.
Main Methods:
- A multiclass random forest model was trained and validated on a national primary care database (n=19,004) to predict optimal levothyroxine dosing classes.
- Key predictive features identified included TSH, fT4, weight, and age.
- A clinical simulation study involved 51 general practitioners prescribing levothyroxine for 20 cases, with and without MIPD support.
Main Results:
- The MIPD model achieved a weighted AUC of 0.71 for predicting dosing classes, demonstrating effectiveness even in subclinical hypothyroidism.
- MIPD significantly reduced overdosage rates (30.5% to 23.9%) and magnitude (median 50 to 37.5 μg).
- The use of MIPD increased the prescription of optimal starting dosages (18.3% to 30.2%) and GPs considered lab results more frequently.
Conclusions:
- The developed MIPD application is the first of its kind for levothyroxine in primary care, demonstrating clinical relevance and safety.
- MIPD effectively assists general practitioners in selecting safer and more optimal starting levothyroxine dosages.
- The study highlights the potential of AI-driven decision support to enhance precision medicine and improve patient outcomes in routine clinical practice.
More Related Videos
04:42A Personalized 3D-Printed Model for Preoperative Evaluation in Thyroid Surgery
Published on: February 17, 2023
13:54A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
Published on: August 18, 2023
Related Concept Videos
Rational Dosage Regimen: Maintenance Dose and Loading Dose
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
Dosage Regimen: Fixed Dose
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
One-Compartment Open Model for IV Bolus Administration: General Considerations
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
Analysis of Population Pharmacokinetic Data
